Phase 1 trial of CZ48 (camptothecin) capsules
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2016
At a glance
- Drugs Camptothecin (Primary)
- Indications Cancer
- Focus Adverse reactions
- 11 Apr 2016 Status changed from planning to recruiting, according to an NMT Pharmaceuticals media release.
- 26 Nov 2013 This trial is expected to be initiated in the first quarter of 2014, and is expected to take 2 years to complete, according to a NanoMaterials Technology media release.
- 26 Nov 2013 New trial record